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Background:  There has been an increasing number of echocardiograms ordered for bacteremia and infective endocarditis (IE) in our lab. It is 
unclear whether patient factors or changing microbiology is the principal source. Therefore, we studied our experience with IE in 1999 compared to 
2009.
Methods:  We screened the results of 14,235 echoes performed for fever or bacteremia (5,012 in 1999 and 9,223 in 2009). Medical records of 
patients with vegetations were further reviewed to confirm IE by the modified Duke criteria.
Results:  27 cases were identified in 1999 compared to 45 in 2009. The number of cases of IE was greater in 2009, but proportional to the 
increase in echoes performed. Gender, age, and past medical history were similar for the two groups, and the frequency of staphylococcal IE did not 
change. There was no significant change in aortic, mitral, or pulmonic valve involvement. However, the number of tricuspid valve (TV) cases increased 
significantly. There was also an increase in valvular complications (abscess, perforation, and flail) and surgery for severe regurgitation. There was a 
trend towards more intravenous drug abuse (IVDA) and indwelling catheters or implanted devices. The overall mortality rates were unchanged.
Conclusions:  There has been a rise in complicated cases of IE and TV involvement, which may be attributed to increasing IVDA and use of 
catheters and devices. Endocarditis is an evolving disease with changing clinical presentation and continues to cause significant mortality.
Results
Variable
1999
N=27
2009
N=45
P Value
History of IVDA 3 (11.1%) 13 (28.9%) 0.142
Indwelling catheters or implanted devices 8 (29.6%) 22 (48.9%) 0.141
Staphylococcal bacteremia 11(40.7%) 25 (55.6%) 0.330
Native valve endocarditis 18 (66.7%) 34 (75.6%) 0.429
Prosthetic valve endocarditis 7 (25.9%) 2 (4.4%) 0.012
Tricuspid valve vegetations 1 (3.7%) 16 (35.6%) 0.002
Vegetation size > 10mm 11(40.7%) 21(46.7%) 0.807
Valve complications or surgery 7 (25.9%) 23 (51.1%) 0.049
Mortality 8 (29.6%) 17 (37.8%) 0.611
